Modeling Down syndrome in cells: From stem cells to organoids

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Down Syndrome (DS) is a chromosomal disorder with significant neurological manifestations.
• Studying DS neurodevelopment and neurodegeneration is crucial but challenged by limited primary neuronal cell availability.
• Various cellular models have been developed to overcome these limitations.

Purpose of the Study:

• To review and discuss the utility of different cellular models in understanding Down Syndrome.
• To highlight advancements in genetic modification technologies for DS research.
• To explore the potential of emerging models like cerebral organoids for DS neural phenotype studies.

Main Methods:

• Review of existing literature on Down Syndrome cellular models.
• Discussion of techniques for genetic modification and trisomy correction in cellular models.
• Exploration of novel approaches including human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs).

Main Results:

• Human:mouse hybrid cells, transchromosomic mouse ESCs, and human ESC/iPSC-derived models have provided valuable insights into DS.
• Genetic modification technologies enable targeted studies of trisomy in DS cellular models.
• Cerebral organoids represent a promising frontier for modeling DS neural phenotypes.

Conclusions:

• Diverse cellular models are essential tools for dissecting the complexities of Down Syndrome.
• Advancements in genetic engineering and organoid technology are enhancing DS research capabilities.
• Future research leveraging these models will deepen our understanding of DS-related neurodevelopment and neurodegeneration.